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Two influenza variants, differing only by 
one mutation, can cooperate to improve 
viral growth in cells in culture. 
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To replicate effectively, viruses must be able to enter and exit host cells.  Neuraminidase (NA) is an 
enzyme on the influenza virus capsid that mediates exit from host cells by cleaving the virion from 
receptors on the host cell surface.  A specific amino acid residue in the NA enzyme catalytic site, 
aspartic acid 151 (D151), has been shown to be required for cleavage activity.  Interestingly 
however, different amino acids have been observed at this position in H3N2 influenza viruses 
sequenced since 2007.  The point mutations D151G and D151N, as well as an "ambiguous" 
nucleotide at that position, have been documented in the GISAID EpiFlu database since 
2007.  Isolated strains of influenza from clinical samples are usually passaged through cells cultured 
in vitro to grow enough virus for sequencing.  Because having a glycine (G) or asparagine (N) rather 
than aspartic acid (D) at residue 151 of NA should prevent cleavage activity and prevent the virus 
from exiting cells, scientists have suggested that the increased frequency of the G151 and N151 flu 
variants is likely an artifact of passaging the virus in vitro.  However, researchers in Dr. Jesse 
Bloom’s laboratory (Basic Sciences) hypothesized that genetically distinct flu viruses might work 
together to improve viral growth.  Their research, recently published in eLife, provides evidence that 
cooperation occurs when two particular viral variants are grown in cell culture.  It also suggests that 
cooperation between viruses could be an unappreciated facet of influenza evolution and infection in 
natural populations.    
May 16, 2016 SCIENCE SPOTLIGHT 
 
2 Volume 6, Issue 5 | Fred Hutchinson Cancer Research Center 
 
The scientists genetically engineered strains of human H3N2 virus with either aspartic acid or 
glycine (D or G) at position 151 of the NA enzyme.  They inoculated human cells in culture with pure 
populations of either variant alone or a mixture of the two viral variants and they measured viral titer 
(growth).  Interestingly, they found that inoculating cells with a mixture of D151/G151 viruses led to 
higher viral titers than those seen with either variant on its own.  If the two H3N2 variants cooperate, 
one would expect a stable proportion of the two to appear and then be maintained over time.  Thus 
the scientists performed serial passaging experiments with pure D151, G151, and mixed D151/G151 
viruses and sequenced viruses after each passage.  They found that cells initially infected with D151 
virus alone accumulate G151 viruses over time and vice versa for cells starting with G151 
virus.  When beginning with a 50/50 mixture of D151/G151, the researchers observed that the 50/50 
proportion of D151 and G151 was maintained over time, through 5 serial passages.  It is of note that 
the G151 variant did not continue to increase in frequency through serial passage, suggesting it is 
not simply an adaptation to the artificial lab conditions. 
Each influenza virus can only have one copy of the neuraminidase (NA) gene.  Therefore, the 
scientists knew that if cooperation among viruses was actually happening, it should depend on the 
concentration of viruses, called multiplicity of infection (MOI).  In agreement with this, the scientists 
found that during an infection with low MOI (fewer viruses), the mixed D151/G151 viruses grew 
indistinguishably from pure D151 H3N2 viruses.   
Given the appearance of the G151 NA variant in H3N2 viruses since 2007, the scientists 
hypothesized that compensatory mutations in other viral genes led to the rise of G151 NA. They 
postulated that the G151 NA variant, which should bind but not cleave host cell surface receptors, 
might be adaptive for viruses with mutations that weaken receptor binding.  Therefore, they cloned 
the sequence of the influenza receptor binding protein hemagglutinin (HA) from H3N2 viruses 
isolated in 2005 and 2007.  As before, a mixture of D151/G151 NA viruses had enhanced viral 
growth when the viruses had the 2007 HA sequence.  Intriguingly however, they found that the 
mixture of D151/G151 NA viruses did not grow better than the D151 variant in combination with the 
HA sequence from 2005.  Finally, to test whether a 50/50 mixture of D151/G151 virus could perform 
both the receptor binding and cleaving functions of H3N2, they measured whether this population of 
viruses could grow when the HA protein could not bind receptors.  Strikingly, they found that the 
D151/G151 NA virus population could grow well even in the absence of functional HA, while pure 
populations of either D151 or G151 NA virus could not grow when HA was inactivated.   
So why don’t we see more mutations at position 151 of NA in unpassaged flu viruses?  The 
scientists hypothesize that the sensitivity of sequencing is not always sufficient to detect low-copy 
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variation in the population.  To this end, they are "working now on sequencing flu from patient 
samples to try to understand whether cooperation is something that occurs in clinical infections," 
said author Katherine Xue.  
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